Postmarket Surveillance of Neuroendovascular Devices.

While the subscription fees for most of these Patient Safety Organization–based quality outcome databases are nonsignificant, there are highly significant costs associated with the resources needed to enter, monitor, and query data.

also in 132,142 other papers